Institution
MUSC Hollings Cancer Center
Also known as: Hollings Cancer Center · Medical University of South Carolina Cancer Center · Medical University of South Carolina Hollings Cancer Center · HCC
- 52running trials
- 24closed trials
- 2,996publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Recruiting
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruiting
Recruiting
Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
Recruiting
Recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Recruiting
Active, not recruiting
Recruiting
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Recruiting
Recruiting
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Recruiting
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Active, not recruiting
Active, not recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Active, not recruiting
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Recruiting
Recruiting
Recruiting
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Active, not recruiting
Active, not recruiting
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Showing 50 of 52.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer6 recruiting
- Ovarian cancer5 recruiting
- Prostate cancer5 recruiting
- Head and neck cancer4 recruiting
- Triple-negative breast cancer3 recruiting
- Brain metastases2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Kidney cancer2 recruiting
- Multiple myeloma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Pancreatic cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Glioblastoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Terminated
Completed
Terminated
Terminated
Completed
Completed
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Terminated
Completed
Completed
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
Completed
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Terminated
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Completed
Completed
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
Completed
Completed
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Completed
Registry name variants (23)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Medical University of South Carolina - Hollings Cancer Center
Charleston, South Carolina 29425
25 trials
MUSC Hollings Cancer Center
Charleston, South Carolina 29425
15 trials
Hollings Cancer Center
Charleston, South Carolina 29425
8 trials
Hollings Cancer Center at Medical University of South Carolina
Charleston, South Carolina 29425
7 trials
Medical University of South Carolina (MUSC) - Hollings Cancer Center
Charleston, South Carolina 29425
3 trials
Hollings Cancer Center at MUSC (HCC)
Charleston, South Carolina 29425
1 trial
NCT07040566A Trial of Varenicline for E-cigarette Cessation
Contact: Lisa Fucito, PhD
Hollings Cancer Center - MUSC
Charleston, South Carolina 29425
1 trial
Contact: Recruitment Coordinator
Hollings Cancer Center (Site 0007)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina - Hollings Cancer Center - PPDS
Charleston, South Carolina 29425-8900
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 0016)
Charleston, South Carolina 29425
1 trial
Contact: Study Coordinator
Medical University of South Carolina-Hollings Cancer Center (Site 0029)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 0045)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 0050)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 0177)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 1934)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina-Hollings Cancer Center (Site 3426)
Charleston, South Carolina 29425
1 trial
Medical University of South Carolina (MUSC) - Hollings Cancer Center (HCC)
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center (HCC)
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center (Site 1715)
Charleston, South Carolina 29425
1 trial
MUSC Hollings Cancer Center (Site 1819)
Charleston, South Carolina 29425
1 trial
Institution data: ROR 00w52vt71 (CC0-1.0)Updated 15 Nov 2026